C12N 2760/16151
Methods of production or purification of viral material
C12N2760/16151 (Methods of production or purification of viral material) appears on 330 US grants and 475 published applications in this corpus.
Search patents in C12N- Granted patents
- 330
- Published applications
- 475
- Assignees
- 241
- Inventors
- 771
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 3 | 0 |
| 1999 | 1 | 0 |
| 2000 | 6 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 2 |
| 2003 | 3 | 7 |
| 2004 | 2 | 3 |
| 2005 | 4 | 10 |
| 2006 | 2 | 10 |
| 2007 | 5 | 13 |
| 2008 | 2 | 15 |
| 2009 | 11 | 23 |
| 2010 | 6 | 23 |
| 2011 | 7 | 24 |
| 2012 | 12 | 28 |
| 2013 | 11 | 30 |
| 2014 | 21 | 27 |
| 2015 | 21 | 27 |
| 2016 | 26 | 42 |
| 2017 | 17 | 30 |
| 2018 | 28 | 26 |
| 2019 | 30 | 23 |
| 2020 | 22 | 25 |
| 2021 | 19 | 16 |
| 2022 | 15 | 20 |
| 2023 | 10 | 16 |
| 2024 | 17 | 18 |
| 2025 | 11 | 12 |
| 2026 | 7 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Avian influenza vaccines and methods of making same28 Jul 2026US 12,691,170 B2The United States of America as represented by the Secretary of Agriculture
- MDCK suspension cell lines in serum-free, chemically-defined media for vaccine production30 Jun 2026US 12,667,612 B2Fujifilm Biosciences Inc.
- Influenza virus backbone5 May 2026US 12,616,745 B2FluGen, Inc.
- Method of labelling viral particles comprising anionic lipids with fluorescently-labelled negatively-charged polynucleotides in the presence of polyvalent cations21 Apr 2026US 12,607,635 B2Oxford University Innovation Limited
- Method for producing reassortant influenza viruses17 Mar 2026US 12,576,146 B2Seqirus UK Limited
- Purification of viruses, virus-like particles, and globular biomolecules by filtration-supported polyalkylene glycol precipitation30 Jul 2026US 2026/0216667 A1
- Influenza virus backbone9 Jul 2026US 2026/0191948 A1FluGen, Inc.
- Crystalline-protein-based platform using viral nucleocapsid for producing target-protein-fused self-assembled nanoparticles9 Jul 2026US 2026/0193661 A1University-Industry Foundation, Yonsei University
- Method for Producing Purified Liquid Having Increased Purity of Separation Target Substance, and Purification Kit for Purifying Separation Target Substance25 Jun 2026US 2026/0177463 A1National Institute of Advanced Industrial Science and Technology
- Modified influenza viruses12 Mar 2026US 2026/0071191 A1Seqirus Inc.
Most cited
By later US patents
- DNA transfection system for the generation of infectious influenza virus91US 6,951,754 B2St. Jude Children?S Research Hospital · 2005
- Production of orthomyxoviruses in monkey kidney cells using protein-free media88US 6,146,873 ABaxter Aktiengesellschaft · 2000
- Method for producing viruses and vaccines in serum-free culture87US 5,753,489 AImmuno Aktiengesellschaft · 1998
- Animal cells and processes for the replication of influenza viruses57US 6,656,720 B2Chiron Behring GmbH & Co. · 2003
- Influenza virus replicated in mammalian cell culture and vaccine production54US 6,344,354 B12002